Jane Street Group, LLC Genetron Holdings LTD Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.8 - $1.12 $52,274 - $73,184	65,343 New	65,343 $73,000
Q2 2022 Aug 16, 2022	BUY	$1.28 - $2.4 $39,461 - $73,989	30,829 New	30,829 $52,000
Q3 2021 Nov 16, 2021	SELL	$11.55 - $20.3 $170,212 - $299,161	-14,737 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$17.9 - $23.29 $107,024 - $139,250	-5,979 Reduced 28.86%	14,737 $297,000
Q1 2021 May 18, 2021	SELL	$13.71 - $30.64 $124,980 - $279,314	-9,116 Reduced 30.56%	20,716 $445,000
Q4 2020 Feb 17, 2021	BUY	$9.31 - $14.0 $277,735 - $417,648	29,832 New	29,832 $418,000

7.5K

Ticker GTH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 90,602,304
Description
Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. It also provides in-vitro diagn...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.